Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials

OBJECTIVE: To examine the association between dipeptidyl peptidase-4 inhibitors and gallbladder or biliary diseases. DESIGN: Systematic review and pairwise and network meta-analysis. DATA SOURCES: PubMed, EMBASE, Web of Science, and CENTRAL from inception until 31 July 2021. ELIGIBILITY CRITERIA: Ra...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Liyun, Wang, Jialu, Ping, Fan, Yang, Na, Huang, Jingyue, Li, Wei, Xu, Lingling, Zhang, Huabing, Li, Yuxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237836/
https://www.ncbi.nlm.nih.gov/pubmed/35764326
http://dx.doi.org/10.1136/bmj-2021-068882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237836/
https://www.ncbi.nlm.nih.gov/pubmed/35764326
http://dx.doi.org/10.1136/bmj-2021-068882

Ejemplares similares